MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares
$16,96
Fiyat · May 20, 2026
Temel veriler itibarıyla May 11, 2026
52 Haftlık Aralık
$6–$63
19% of range
Analist Derecelendirmesi
BUY
23 analysts
Fiyat Hedefi
$28
+63% upside
P/E (TTM)
-3.7
ROE
-60.5%
Net Kâr Marjı
—
MLTX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$16.96
Piyasa Değeri
—
P/E (TTM)
-3.7
EPS (TTM)
$-3.53
Gelir (TTM)
—
Temettü Verimi
—
ROE
-60.5%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$6 – $63
MLTX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
—
Hisse Başına Kâr
$-3.53
2022-12-31
→
2025-12-31
Serbest Nakit Akışı
$-196M
2022-12-31
→
2025-12-31
Marjlar
—
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
MLTX
Akran Ortalaması
P/E (TTM)
-3.7
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
MLTX
Akran Ortalaması
ROA
-50.4%
-44.7%
ROE
-60.5%
-83.5%
ROIC
-80.6%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
MLTX
Akran Ortalaması
Current Ratio (Cari Oran)
9.3
4.1
Quick Ratio (Cari Oran)
7.4
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
MLTX
Akran Ortalaması
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
MLTX
Akran Ortalaması
MLTX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
23 analist
- Güçlü Al 8 34,8%
- Al 10 43,5%
- Tut 3 13,0%
- Sat 1 4,3%
- Güçlü Sat 1 4,3%
12 Aylık Fiyat Hedefi
13 analist · 2026-05-17
Medyan
$30.00
Şimdi
$16.96
Düşük
$6.00
Yüksek
$46.00
Medyan hedef
$30.00
+76,9%
Ortalama hedef
$27.62
+62,8%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.04%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.98 | $-0.91 | -0.07% |
| 31 Aralık 2025 | $-0.92 | $-1.01 | 0.09% |
| 30 Eylül 2025 | $-1.10 | $-0.90 | -0.20% |
| 30 Haziran 2025 | $-0.87 | $-0.74 | -0.13% |
| 31 Mart 2025 | $-0.63 | $-0.77 | 0.14% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| MLTX | — | -3.7 | — | — | -60.5% | — |
| CRSP | $5.03B | -8.1 | -90.6% | -16569.8% | -32.0% | — |
| ADCT | $444M | -3.2 | 14.8% | -175.3% | 74.1% | — |
| ACIU | — | — | — | — | — | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $203M | $113M | $32M | $42M | · | |
| SG&A Expense | $42M | $30M | $22M | $23M | $5M | |
| Operating Expenses | $245M | $143M | $54M | $65M | · | |
| Operating Income | $-245M | $-143M | $-54M | $-65M | $-5M | |
| Interest Income | · | · | · | · | $27.7K | |
| Other Non-op | · | · | · | $591.7K | $27.7K | |
| Pretax Income | $-230M | $-121M | $-44M | $-64M | · | |
| Income Tax | $611.0K | $282.0K | $94.0K | $36.4K | · | |
| Net Income | $-227M | $-119M | $-36M | $-50M | $-5M | |
| EPS (Basic) | $-3.53 | $-1.89 | $-0.73 | $-1.70 | · | |
| EPS (Diluted) | $-3.53 | $-1.89 | $-0.73 | $-1.70 | · | |
| Shares (Basic) | 64,463,889 | 62,870,237 | 49,122,534 | 29,361,353 | · | |
| Shares (Diluted) | 64,463,889 | 62,870,237 | 49,122,534 | 29,361,353 | 360,000,000 | |
| EBITDA | $-242M | $-142M | · | $-65M | $-5M |
Bilanço 21
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $335M | $180M | $451M | $40M | $8M | |
| Prepaid Expense | $23M | $23M | $2M | $4M | $1M | |
| Current Assets | $422M | $474M | $514M | $77M | $10M | |
| PP&E (Net) | $577.0K | $722.0K | $320.9K | $49.4K | $45.7K | |
| Other Non-current Assets | $596.0K | $0 | · | · | · | |
| Total Assets | $424M | $478M | $527M | $77M | $10M | |
| Accrued Liabilities | · | · | · | · | $4M | |
| Short-term Debt | · | · | · | $0 | $15M | |
| Current Liabilities | $45M | $22M | $10M | $8M | $21M | |
| Capital Leases | $374.0K | $1M | $2M | $129.0K | $0 | |
| Total Liabilities | $120M | $25M | $13M | $8M | $21M | |
| Long-term Debt | $74M | $0 | · | · | · | |
| Total Debt | · | · | · | $0 | · | |
| Common Stock | · | · | · | $0 | $38.5K | |
| Paid-in Capital | $767M | $677M | $610M | $129M | $42M | |
| Retained Earnings | $-463M | $-236M | $-117M | $-81M | $-54M | |
| Treasury Stock | · | · | · | $0 | $6.2K | |
| AOCI | $604.0K | $5M | $2M | $350.9K | $-168.2K | |
| Stockholders' Equity | $304M | $447M | $496M | $49M | $-12M | |
| Liabilities + Equity | $424M | $478M | $527M | $77M | $10M | |
| Shares Outstanding | · | · | · | · | 12,161,331 |
Nakit Akışı 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $3M | $1M | $370.0K | $164.8K | · | |
| Stock-based Comp | $13M | $7M | $7M | $10M | · | |
| Other Non-cash | $16M | $-6M | · | · | · | |
| Operating Cash Flow | $-196M | $-117M | $-43M | $-56M | $-611.1K | |
| CapEx | $35.0K | $520.0K | $284.0K | $16.0K | · | |
| Investing Cash Flow | $203M | $-206M | $-25M | $-32M | · | |
| Debt Issued | $73M | $0 | $0 | · | · | |
| Net Debt Issued | $73M | · | · | · | · | |
| Stock Repurchased | · | $50 | $0 | $0 | · | |
| Net Stock Activity | · | $-50 | · | · | · | |
| Financing Cash Flow | $146M | $51M | $480M | $120M | $-58.1K | |
| Net Change in Cash | $154M | $-271M | $412M | $31M | $-669.1K | |
| Taxes Paid | $799.0K | $147.0K | $42.0K | $4.3K | · | |
| Free Cash Flow | $-196M | $-117M | · | $-56M | · |
Kârlılık 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -50.4% | -23.7% | · | -115.5% | -3.9% | |
| ROE | -60.5% | -25.2% | · | -268.3% | 94.1% | |
| ROIC | -80.6% | -32.1% | · | -133.1% | · |
Likidite ve Solventlik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 9.3 | 21.1 | · | 10.0 | 0.2 | |
| Quick Ratio | 7.4 | 8.0 | · | 5.2 | 0.2 | |
| Debt / Equity | · | · | · | 0.0 | · |
Değerleme (TTM) 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-227M | $-119M | $-36M | $-50M | $-5M | |
| P/E | -3.7 | -28.7 | -82.7 | -6.2 | · | |
| Earnings Yield | -26.8% | -3.5% | -1.2% | -16.2% | · |
Gelir Tablosu 14
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $55M | $56M | $61M | $50M | $36M | $40M | $36M | $24M | $13M | $8M | $9M | $7M | $9M | $11M | $10M | · | |
| SG&A Expense | $16M | $9M | $11M | $11M | $11M | $9M | $7M | $7M | $7M | $5M | $4M | $6M | $6M | $6M | $5M | $-4M | |
| Operating Expenses | $70M | $65M | $71M | $61M | $47M | $50M | $43M | $31M | $20M | $13M | $13M | $13M | $15M | $18M | $16M | · | |
| Operating Income | $-70M | $-65M | $-71M | $-61M | $-47M | $-50M | $-43M | $-31M | $-20M | $-13M | $-13M | $-13M | $-15M | $-18M | $-16M | $34M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $657 | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $8.4K | $2.3K | |
| Other Non-op | · | · | · | · | · | · | · | · | · | $1M | $842.7K | $723.6K | $37.6K | $245.1K | $69.5K | $34.5K | |
| Income Tax | $622.0K | $248.0K | $115.0K | $95.0K | $153.0K | $41.0K | $92.0K | $79.0K | $70.0K | $28.9K | $10.1K | $11.0K | $8.7K | $9.3K | $7.3K | · | |
| Net Income | $-70M | $-62M | $-70M | $-55M | $-40M | $-46M | $-35M | $-24M | $-14M | $-9M | $-10M | $-9M | $-10M | $-12M | $-16M | $35M | |
| EPS (Basic) | $-0.98 | $-0.93 | $-1.10 | $-0.87 | $-0.63 | $-0.72 | $-0.56 | $-0.39 | $-0.22 | $-0.18 | $-0.23 | $-0.23 | $-0.27 | $-0.34 | $-3.17 | · | |
| EPS (Diluted) | $-0.98 | $-0.93 | $-1.10 | $-0.87 | $-0.63 | $-0.72 | $-0.56 | $-0.39 | $-0.22 | $-0.18 | $-0.23 | $-0.23 | $-0.27 | $-0.34 | $-3.17 | · | |
| Shares (Basic) | 71,273,650 | -125,422,611 | 63,369,984 | 63,282,728 | 63,233,788 | -125,538,394 | 62,896,782 | 62,874,637 | 62,637,212 | 53,517,655 | 43,718,464 | 39,061,977 | 36,925,639 | 35,201,713 | 5,013,646 | · | |
| Shares (Diluted) | 71,273,650 | -125,422,611 | 63,369,984 | 63,282,728 | 63,233,788 | -125,538,394 | 62,896,782 | 62,874,637 | 62,637,212 | 53,517,655 | 43,718,464 | 39,061,977 | 36,925,639 | 35,201,713 | 5,013,646 | 350,310,373 | |
| EBITDA | $-69M | · | $-71M | $-61M | $-47M | · | $-43M | $-31M | $-20M | $-13M | $-13M | $-13M | $-15M | $-18M | $-3M | · |
Bilanço 21
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $298M | $335M | $351M | $307M | $272M | $180M | $376M | $343M | $458M | $318M | $502M | $50M | $41M | $93M | $23.3K | $666.8K | |
| Prepaid Expense | $33M | $23M | $27M | $27M | $23M | $23M | $16M | $15M | $5M | $3M | $4M | $3M | $4M | $5M | $135.9K | $126.9K | |
| Current Assets | $397M | $422M | $411M | $455M | $506M | $474M | $512M | $537M | $554M | $500M | $506M | $67M | $89M | $98M | $116M | $793.7K | |
| PP&E (Net) | $532.0K | $577.0K | $622.0K | $667.0K | $711.0K | $722.0K | $581.4K | $481.7K | $509.8K | $39.5K | $42.8K | $46.1K | $52.7K | $56.0K | · | · | |
| Other Non-current Assets | $1M | $596.0K | $587.0K | $2M | $2M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $400M | $424M | $414M | $460M | $511M | $478M | $518M | $545M | $564M | $500M | $507M | $67M | $89M | $98M | $231M | $116M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6M | $4M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $150.0K | · | |
| Current Liabilities | $46M | $45M | $48M | $27M | $24M | $22M | $20M | $12M | $9M | $10M | $7M | $7M | $6M | $4M | $203M | $4M | |
| Capital Leases | $865.0K | $374.0K | $486.0K | $836.0K | $1M | $1M | $2M | $2M | $2M | $13.1K | $53.0K | $91.1K | · | · | · | · | |
| Total Liabilities | $146M | $120M | $123M | $102M | $99M | $25M | $23M | $15M | $12M | $11M | $8M | $8M | $6M | $4M | $207M | $8M | |
| Long-term Debt | $99M | $74M | $74M | $73M | $73M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $150.0K | · | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $385 | $43 | |
| Paid-in Capital | $786M | $767M | $689M | $684M | $681M | $677M | $675M | $672M | $670M | $531M | $590M | $131M | $124M | $122M | $34M | · | |
| Retained Earnings | $-533M | $-463M | $-400M | $-331M | $-276M | $-236M | $-190M | $-155M | $-130M | $-109M | $-100M | $-90M | $-69M | $-59M | $-10M | $-7M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | |
| AOCI | $322.0K | $604.0K | $278.0K | $520.0K | $2M | $5M | $3M | $3M | $3M | $3M | $35.1K | $340.1K | $245.3K | $133.7K | · | · | |
| Stockholders' Equity | $254M | $304M | $289M | $354M | $408M | $447M | $488M | $521M | $543M | $425M | $490M | $42M | $55M | $64M | $24M | $-7M | |
| Liabilities + Equity | $400M | $424M | $414M | $460M | $511M | $478M | $518M | $545M | $564M | $500M | $507M | $67M | $89M | $98M | $231M | $116M | |
| Shares Outstanding | · | · | · | · | · | · | · | · | · | · | · | · | 0 | 0 | · | · |
Nakit Akışı 15
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $845.0K | $751.0K | $745.0K | $742.0K | $378.0K | $364.0K | $351.0K | $342.0K | $328.0K | · | · | · | · | · | · | · | |
| Stock-based Comp | $13M | $4M | $4M | $3M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $3M | $3M | $2M | $2M | · | |
| Other Non-cash | $-11M | · | · | · | $-864.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-66M | $-59M | $-45M | $-55M | $-38M | $-48M | $-25M | $-28M | $-15M | $-9M | $-12M | $-9M | $-9M | $-34M | $-14M | $27M | |
| CapEx | $0 | $0 | $0 | $0 | $35.0K | $176.0K | $132.2K | $235 | $212.0K | $0 | $0 | $0 | $0 | $-2 | $16.0K | · | |
| Investing Cash Flow | $98.0K | $-30M | $88M | $88M | $56M | $-147M | $58M | $-88M | $-29M | $-174M | $13M | $20M | $-42M | $2 | $-16.0K | · | |
| Debt Issued | $24M | $0 | $0 | $0 | $73M | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | |
| Net Debt Issued | $24M | · | · | · | $73M | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $6M | · | $0 | $0 | $0 | · | $-190 | $-190 | $53M | $0 | $451M | $0 | $0 | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | $0 | $0 | $50 | $0 | $0 | $0 | · | · | · | · | |
| Net Stock Activity | $6M | · | · | · | $0 | · | · | · | $53M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $31M | $72M | $480.0K | $0 | $73M | $151.0K | $183.1K | $95 | $51M | $0 | $451M | $0 | $0 | $120M | $15M | $-28M | |
| Net Change in Cash | $-36M | $-16M | $44M | $35M | $91M | $-195M | $33M | $-116M | $7M | $-184M | $452M | $11M | $-52M | $85M | $795.3K | $-1M | |
| Taxes Paid | · | $733.0K | · | · | · | $143.0K | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-66M | · | · | · | $-38M | · | · | · | $-15M | · | · | $-9M | · | · | · | · |
Kârlılık 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -15.3% | · | -14.9% | -11.0% | -7.4% | · | -7.0% | -4.6% | -4.3% | -3.2% | -3.4% | -6.0% | -9.9% | -11.3% | -1.6% | · | |
| ROE | -21.1% | · | -17.9% | -12.6% | -8.4% | · | -7.8% | -4.8% | -4.7% | -3.9% | -3.7% | -27.1% | -40.1% | -35.4% | -18.4% | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.6 | · | 8.5 | 16.6 | 21.1 | · | 25.5 | 43.7 | 62.1 | 48.5 | 71.0 | 9.1 | 14.7 | 25.5 | 0.6 | · | |
| Quick Ratio | 6.5 | · | 7.3 | 11.2 | 11.3 | · | 18.7 | 27.9 | 51.4 | 30.9 | 70.3 | 6.9 | 6.8 | 24.0 | 0.0 | · | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -4127.1 | · |
Değerleme (TTM) 7
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-235M | · | $-200M | $-155M | $-113M | · | $-83M | $-58M | $-42M | $-39M | $-41M | $-47M | $-44M | $-67M | $-55M | · | |
| Market Cap | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | $-41M | $-93M | · | · | |
| P/E | -5.2 | · | -2.3 | -19.3 | -21.7 | · | -37.3 | -43.1 | -58.4 | -62.6 | -47.7 | -5.3 | -1.2 | -0.6 | · | · | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | · | 2.8 | 5.3 | · | · | |
| Earnings Yield | -19.2% | · | -44.1% | -5.2% | -4.6% | · | -2.7% | -2.3% | -1.7% | -1.6% | -2.1% | -18.8% | -82.6% | -172.2% | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Net Gelir | $-227M | $-119M | $-36M | $-50M | $-5M |
| Seyreltilmiş Hisse Başı Kâr | $-3.53 | $-1.89 | $-0.73 | $-1.70 | — |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | — | — | — | 0.0 | — |
| Cari Oran | 9.3 | 21.1 | — | 10.0 | 0.2 |
| Cari Oran | 7.4 | 8.0 | — | 5.2 | 0.2 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-196M | $-117M | — | $-56M | — |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.